SCHEMBL30997189

SCHEMBL30997189

CC(=O)Oc1ccccc1CCl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 11/20 0.52
KDM4E B2RXH2 2/20 0.52
HSD17B10 Q99714 2/20 0.52
ALDH1A1 P00352 2/20 0.52
ESR1 P03372 1/20 0.52
ITGB3 P05106 1/20 0.52
ITGA2B P08514 1/20 0.52
HMGB1 P09429 1/20 0.52
HPGD P15428 1/20 0.52
TSHR P16473 1/20 0.52
GGT1 P19440 1/20 0.52
PTGS1 P23219 1/20 0.52
BLM P54132 1/20 0.52
NAPRT Q6XQN6 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
LMNA P02545 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
MAPT P10636 2/20 0.44
HSP90AA1 P07900 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL248688 1.00 PTGS2 (0.52) PTGS2KDM4EHSD17B10ALDH1A1ESR1
Benzene SCHEMBL3150461 0.98 PTGS2 (0.55) PTGS2KDM4EHSD17B10ALDH1A1ESR1
Naphthalene SCHEMBL3155078 0.95 PTGS2 (0.47) PTGS2KDM4EHSD17B10ALDH1A1ESR1
SCHEMBL4328045 0.89 HSD17B10 (0.65) PTGS2KDM4EHSD17B10ALDH1A1ESR1
SCHEMBL609102 0.84 CXCL8 (0.40) KDM4EHSD17B10ALDH1A1HPGDTSHR
SCHEMBL11589528 0.84 PTGS2 (0.55) PTGS2KDM4EHSD17B10ALDH1A1ESR1
SCHEMBL68677 0.84 PTGS2 (0.55) PTGS2KDM4EHSD17B10ALDH1A1ESR1
SCHEMBL30850062 0.84 PTGS2 (0.55) PTGS2KDM4EHSD17B10ALDH1A1ESR1
SCHEMBL10924111 0.82 PTGS2 (0.53) PTGS2KDM4EHSD17B10ALDH1A1ESR1
SCHEMBL3628841 0.82 PTGS2 (0.53) PTGS2KDM4EHSD17B10ALDH1A1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118556043-A Treatment of signs, symptoms and/or complications of viral, bacterial, protozoal and/or fungal infections by highly penetrating prodrugs 苏州泰飞尔医药有限公司 2024-08-27 CN disclosed